Search PDMR transactions

Notifier
Name of person with notification obligation
Sören Tulstrup
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Sören Tulstrup
Position
Chief Executive Officer (CEO)/Managing Directory
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
Hansa Biopharma AB
Issuer´s LEI code
549300LLEO25ZJJ3NT91
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Share Hansa Biopharma AB SE0002148817 Acquisition 5,000 Quantity 23.02836 SEK 07/12/2023 DANSKE BANK A/S - SYSTEMATIC INTERNALISER
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
Hansa Biopharma AB SE0002148817 Acquisition 07/12/2023 DANSKE BANK A/S - SYSTEMATIC INTERNALISER 5,000 (Quantity) 23.02836 SEK
Total: 5,000
<< Back